You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

52 Results
Guidelines and Advice
Status: Current
ID: GL-C50-20
May 2015
Guidelines and Advice
Status: Current
ID: GL-C50-34
Aug 2017
Guidelines and Advice
Status: Current
ID: GL-END MOTAC 5
Aug 2017
Drug
Other Name(s): Provera® (multiple brands available)
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2015
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Palliative
Drugs Used:
CISplatin,
fluorouracil
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2017
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
etoposide,
leucovorin,
fluorouracil
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2017
Regimen
Cancer Type:
Central Nervous System
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
vinBLAStine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2017
Guidelines and Advice
Status: Current
ID: GL-C50-33
Version: 1
Aug 2017
Guidelines and Advice
Status: Current
ID: GL-C50-19
Jan 2015
Cancer facts
Aug 2017
Statistical Reports
Sep 2015
Statistical Reports
Sep 2015

Pages